Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer

Subing Cao1, Tianfang Ma1, Nathan Ungerleider2

  • 1Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.

Oncogene
|August 15, 2019
PubMed

Insights

Circular RNAs (circRNAs) from the androgen receptor (AR) gene are upregulated in metastatic castration-resistant prostate cancer. These AR circRNAs may serve as novel biomarkers for disease progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly linked to various cancers.
  • Metastatic castration-resistant prostate cancer (mCRPC) is a leading cause of cancer mortality.
  • Limited research exists on circRNAs in mCRPC, particularly those derived from the androgen receptor (AR) gene.

Purpose of the Study:

  • To identify and characterize circRNAs originating from the androgen receptor (AR) gene in metastatic castration-resistant prostate cancer.
  • To investigate the expression patterns and regulatory mechanisms of AR-derived circRNAs during castration resistance.
  • To explore the potential of AR circRNAs as diagnostic or prognostic biomarkers for mCRPC.

Main Methods:

  • Analysis of exome-capture RNA-sequencing data from 47 mCRPC samples.
  • RNA sequencing of patient-derived xenografts (PDXs) and cell models after ribodepletion and RNase R treatment.
  • Validation and characterization of top AR circRNAs using molecular assays.
  • Nuclear/cytoplasmic fractionation and RNA in-situ hybridization.

Main Results:

  • Thirteen circRNAs were identified from the AR gene in mCRPC samples.
  • The four most abundant AR circRNAs were validated and characterized.
  • AR circRNA expression was upregulated during castration-resistant progression in PDXs, correlating with linear AR transcript levels.
  • Androgen suppressed AR circRNA and linear AR transcript expression in cell models.
  • AR circRNAs were predominantly localized in the cytoplasm.
  • AR circRNAs were detected in patient plasma.

Conclusions:

  • This study provides the first comprehensive characterization of circRNAs derived from the AR gene.
  • AR circRNAs are transcriptionally regulated and their expression is linked to AR signaling.
  • Cytoplasmic localization suggests potential functional roles for AR circRNAs.
  • AR circRNAs show promise as stable circulating biomarkers for AR/AR-variant expression and mCRPC progression.

Related Concept Videos

Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.4K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.5K